Immunology Flashcards

1
Q

What are the two primary lymph tissues

A

Thymus

Bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What’s the difference between primary lymph tissues and secondary lymph tissues

A
Primary = cells originate or mature
Secondary = cells reside and traffic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the two cells that are only involved in adaptive immunity and not innate

A

B cells and T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the two cells involved in both innate and adaptive immunity

A

Natural killer T cell

yG T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the steps of phagocytosis

A
  1. Chemotaxis and adherence of microbe to phagocyte

2 ingestion of microbe by phagocyte

3 formation of a phagosome

4 fusion of the phagosome with a lysosome to form a phagolysosome

5 digestion of ingested microbe by enzymes

6 formation of residual body containing indigestible material

7 discharge of waste materials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what do activated macrophages secrete

A

cytokines and chemokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which MHC classes do CD4 and CD8 interact with

A

CD4 = MHC class II

CD8 = MHC class I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the markers of a B cell

A

CD19 and CD20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the markers of Th cells

A

CD3 and CD4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the markers of Tc cells

A

CD3 and CD8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the marker on all T cells

A

CD3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the marker on NK cells

A

CD16/56

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe the signs of Specific IgA deficiency (sIgAD)

A

IgA protects against infections of the mucous membranes of the GI tract and airways

many asymptomatic

but sometimes associated with infections or autoimmune/allergic disease

next to no IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the signs of X linked agammaglobulinaemia (XLA)

A

Mutations in the BTK gene; X linked
• Causes arrest of B cell development between pro B to B cell stage
• No peripheral B cells in blood
• Failure of immunoglobulin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe type I hypersensitivity

A

IgE- mediated hypersensitivity

ALLERGEN induces a humeral response

  • Secretes IgE antibody in response to activation of allergen-specific TH2 cells
  • normally this happens when there’s a parasitic infection but if you have this then you have IgE regulatory defects (atopy) and that means there’s abnormal production of IgE in response to nonparasitic antigens
  • Ag indices cross-linking of IgE (which is bound to mast cells, eosinophils and basophils) to allergen
  • degranulation occurs
  • leads to local or systemic inflammation
  • IgE Abs bind with High Affinity to Fc eRI receptor on Mast Cells

Three Phases:

  1. Sensitisation phase:
    • Exposure to allergen
    - activates TH2 cells
    - stimulate B cells to form IgE producing plasma cells
    • IgE produced in response to antigenic stimulus and binds to FC- receptors on mast cells and basophils
  2. Activation Phase:
    •Re-exposure to antigen triggers mast cells and basophils to respond by release of their granules
  3. Effector Phase:
    • Complex response occurs as a result of histamine and other pharmacologically active agents released by mast cells and basophils
  • can be systemic (anaphylactic shock) or localised (atopy)
  • Allergic Reactions can have both an immediate phase but also a late-phase response

typically manifests as systemic and localised anaphylaxis such as hay fever, asthma, hives, food allergies and eczema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe type II hypersensitivity

A
  • Involves antibody-mediated destruction of cells
  • cell destruction happens via Antibody-Dependent Cell mediated Cytotoxicity (ADCC)
  • mediated by IgG and IgM
3 types:
- blood transfusions - when incorrect blood type administered body has an immune response to the foreign blood
- haemolytic disease of the newborn 
- drug- induced haemolytic anaemia
(all of these cause haemolysis)

see hypersensitivity lecture for diagram on mode of action of ADCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe type III hypersensitivity

A
  • immune complex-mediated hypersensitivity
  • Reaction of Ab’s with antigen generates immune complexes
    facilitating the clearance by phagocytic cells and mast cell activation
  • In some cases, large amounts of immune complexes can lead to
    tissue damaging type III hypersensitivity reactions
  • Magnitude of the reactions depends on the amount of immune complexes
  • Can be localized and occurs wherever immune complexes are deposited
  • Common sites are blood vessel walls, synovial membrane of joints, glomerular basement membrane of the kidney
  • Deposition of complexes results in the recruitment of neutrophils to the site (granular release)
  • Lytic enzymes causes tissue damage

Examples:

  • Farmer’s lung
  • Pigeon fancier’s disease
  • Serum Sickness (generalised) - when foreign antibodies are injected into human (eg from a mouse or something) - this is why in treatment we need to develop human antibodies treatment and not from animals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe type IV hypersensitivity

A

Delayed-Type Hypersensitivity (DTH)

– Localized inflammatory response induced by T H
cells
– Characterized by large influx of inflammatory cells
and macrophages
– Delayed: 24-72 hours
– DTH is often helpful and plays important role in
intracellular pathogens and contact antigens
– DTH can cause tissue damage and be pathological if the pathogen and contact antigen persists - then DTH just keeps going and causes damage

Main examples:

  • TB
  • herpes
  • measles
  • contact antigens - jewellery, hair dyes etc

sensitisation and effector phase

  • Influx and Activation of macrophages in the DTH response important in host defence against parasites and bacteria that live within cells
  • ie. areas where Ab cannot reach them
  • Normally the intracellular pathogen/infected cell is quickly cleared with little tissue damage, BUT if antigen not easily cleared a prolonged DTH response can occur

Prolonged DTH Response can lead to Granulomas:
- Continuous activation of macrophages:
1. Macrophages adhere to each other
2. Fuse to form multinucleated giant cells
3. Form palpable nodules
4. Release lytic enzymes
5. Tissue Damage
Eg. Mycobacterium tuberculosis in the lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe the autoimmune cause of Grave’s disease

A

– antibodies against hormone receptor
– activate the receptor
– Uncontrolled hormone production
- enlarged thyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

describe the autoimmune cause of Myasthenia gravis

A

– Antibodies against acetylcholine receptor
– Act as an antagonist
– Block binding to receptor
– Severe muscle weakness
– Difficulties chewing, swallowing, breathing
– genetic component HLA-DR3 alleles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

describe the cause and features of Systemic Lupus Erythematosus (SLE) - LUPUS

A

• Chronic, multiorgan disease
• Affects predominantly women
• Characterised by production of autoantibodies
against self DNA/RNA complexes
• Symptoms a result of DNA/ or RNA/Ab complexes
forming and triggering acute inflammation: type III
hypersensitivity

Features:

  • Fever, weakness, arthritis, skin rashes, pleurisy, kidney dysfunction, etc.
  • Autoantibodies to DNA, histones, RBCs, platelets, leukocytes and clotting factors
  • RBCs & platelet autoantibodies lead to complement- mediated lysis of cells causing anaemia and thrombocytopenia
  • Accumulation of immune complexes can be deposited along walls of small blood vessels which leads to type III hypersensitivity reaction
  • why you see a rash forming
  • Activates complement system - leads to tissue damage
22
Q

describe Multiple Sclerosis (MS)

how is it linked to hypersensitivity and autoimmunity

A

Cell-mediated autoimmunity (Type IV hypersensitivity)

• Cell mediated immune attack in Central Nervous
System (CNS)
• Destruction of myelin and axons
• Central role for CD4+ helper T cells
• Self antigen = peptides of myelin - that’s the thing the cells attack
• Targets: myelin, oligodendrocytes, axons
• Numerous cells cause actual damage; prominent
role for macrophages, cytotoxic T cells
- not really known what started it ie why the body starts destroying its myelin and axons

23
Q

what treatments are available for autoimmune diseases

A

no cure

  • Immunosuppression - dampen type 2/3 hypersensitivity
  • Immunomodulation - dampen type 2/3 hypersensitivity
  • Plasmapheresis - clear blood of autoantibodies if there’s an exasberation
  • IVIg - artificially introducing antibodies to individuals
  • Protection of target - if its bound to a particular cell
  • Autologous stem cell transplantation - clear body of T cells and give them new immune system - in extreme cases and need correct donor
  • Tolerance induction / T cell vaccination (in trial) - more experimental
24
Q

what treatments are available for autoimmune diseases

A

no cure

  • Immunosuppression - dampen type 2/3 hypersensitivity
  • Immunomodulation - dampen type 2/3 hypersensitivity
  • Plasmapheresis - clear blood of autoantibodies if there’s an exasberation
  • IVIg - artificially introducing antibodies to individuals
  • Protection of target - if its bound to a particular cell
  • Autologous stem cell transplantation - clear body of T cells and give them new immune system - in extreme cases and need correct donor
  • Tolerance induction / T cell vaccination (in trial) - more experimental

can also treat the symptoms in organ-specific disorders

25
Q

Explain the five cardinal signs of inflammation

A
  • rubor (redness) - due to increased vascularity
  • tumor (swelling) - exudation of fluid
  • calor (heat) - increased blood flow and release of inflammatory mediators
  • dolor (pain) - stretching of pain receptors and nerves by inflammatory exudates and by the release of chemical mediators
  • functio laesa (loss of function) - combination of all of the above
26
Q

Describe the events that occur during acute inflammation

A
  • Local cells move towards site - mast cells and macrophages
  • these release chemical signals
  • causes things like increased blood flow
  • phagocytic cells move in from capillaries to site
  • phagocytosis occurs
27
Q

Discuss possible outcomes of acute inflammation

A

Acute inflammation: relatively short duration (hours to
days): exudation of fluid and plasma protein, neutrophil
and monoctye infiltration

can result in good things:

  • Complete resolution ( back to normal)
  • Healing ( fibrosis)

but also sometimes bad things:

  • Abscess formation
  • Progressing to chronic inflammation
28
Q

describe the three manners in which cytokines can work

A

Autocrine: Cytokine binds
to receptor on cell that
secreted it

Paracrine: Cytokine binds to
receptors on nearby cells

Endocrine: Cytokine binds
cells in distant parts of the
body

29
Q

Give examples of cytokines which are Pro-inflammatory

A
IL- 1
TNF alpha
IL-6
IL-8
IL-12
30
Q

Give examples of cytokines which are Anti-viral

A

interferon α/B

31
Q

what is the difference between the innate response and adaptive response of the immune system

A

Innate:

  • rapid
  • non-specific
  • first line of defence
  • not enhanced by repeated exposure

Adaptive:

  • slow
  • specific
  • second line of defence
  • enhanced by repeated exposure
32
Q

describe the two types od adaptive immunity

A

• Humoral immunity
– Immunity that is mediated by antibodies
– Can be transferred by to a non-immune recipient by serum

• Cell Mediated Immunity
– Immune response in which antigen specific T cells dominate

33
Q

describe Common Variable Immune Deficiency (CVID)

A
– Primary Immune Deficiency 
– Can occur at any age
• Reduction in IgG, IgA and/or IgM
• poor response to vaccines
• defined causes of hypogammaglobulinaemia have been excluded

• CVID is an umbrella term for patients with
antibody deficiency in whom:
– no other primary cause is identified
– no secondary cause for the antibody deficiency has been identified

34
Q

describe treatment of antibody deficiency

A
• sIgA deficiency often needs no treatment 
• Immunoglobulin replacement therapy (IRT) 
• Chest management 
• Prophylactic antibiotics 
• Disease specific complications
– Autoimmune complications may require
immunosuppressive therapy e.g haemolytic
anaemia in CVID
35
Q

describe SCID presentation, laboratory abnormalities, management

A
clinical presentation:
• Infancy 
• Infections
– Bacterial 
– Viral 
– Fungal
• Failure to thrive

Laboratory abnormalities :
• lymphopaenia
• +/- hypogammaglobulinaemia
• Absent T cells or non functioning T cells (depending on the type, they may have absent B and or NK cells)

Management:
• Isolation 
• Antimicrobial therapy 
• Immunoglobulin replacement 
• Talk to the transplant centre: BMT/stem cell therapy for definitive management
36
Q

what are the functions of the complement system

A
  • makes bacteria more susceptible to phagocytosis
  • directly lyses some bacteria and foreign cells
  • produces chemotactic substances - mediates inflammation
  • increases vascular permeability
  • causes smooth muscle contraction - promotes mast cell degranulation
37
Q

describe the pathology of RSV bronchiolitis and pneumonia

A
• Pathology
– Necrosis and sloughing of small airway epithelium
– Oedema
– Increased mucus secretion
• Obstructs airflow in small airways 
– Interstitial infiltration 
– Alveolar filling

• Clinical
– Hyperinflation
– Atelectasis (collapsed lung)
– Wheezing

38
Q

describe RSV pathogenesis

A

• Virus replication triggers immune response in
lungs

– Cytokine/chemokine release

– Infiltration of …
• neutrophils
• lymphocytes
• eosinophils

– Perivascular and peribronchiolar cuffing

– Trapping of air in lower lungs
• lung hyperinflation

• Once the immune response is triggered,
removal of RSV will not stop the pathogenesis

39
Q

What is sepsis and septic shock?

A

• Sepsis
– The presence of SIRS associated with a confirmed infectious process.

• Severe sepsis
– Sepsis with either hypotension or systemic
manifestations of hypoperfusion
• Lactic acidosis, oliguria, altered mental status

• Septic shock
– Sepsis with hypotension despite adequate fluid
resuscitation, associated with hypoperfusion abnormalities

40
Q

describe Systemic inflammatory response syndrome (SIRS)

A

2 or more of following symptoms:
• Temperature >38ºC or <36ºC
• Heart rate >90 beats/min
• Respiratory rate >20 breaths/min or PaCO2 of <32 mmHg
• White blood cell count >12,000 cells/mm3, <4000
cells/mm3, or >10% immature forms

41
Q

what treatments are available for type 1 hypersensitivity reactions

A

Environmental – Avoid “it”

Pharmacologic:

  • Anti-histamines – Blocks H1 and H2 receptors
  • Cromolyn Chloride – Blocks mast cell degranulation if taken before allergen exposure (Nasodex)
  • Corticosteroids – Blocks biosynthesis of histamines and arachidonic acid (leukotrienes and prostaglandins)
  • Theophylline – Blocks degranulation through cAMP prolongation
  • Epinephrine – Counteracts the effects of anaphylaxis shock

Immunological:

  • Hypo or desensitization – Inject with increasing doses of antigen over time; induces IgG Abs to clear antigen prior to IgE binding
  • Humanized Anti-IgE Antibodies – Binds to IgE in serum and used for asthma treatment (Xolair) – £6-18k per year
42
Q

give some examples of organ-specific autoimmune diseases

A

type 1 diabetes

goodpasture’s syndrome

multiple sclerosis

  • graves’ disease
  • Hashimoto’s thyroiditis
  • autoimmune pernicious anemia
  • autoimmune Addison’s disease
  • vitiligo
  • myasthenia gravis
43
Q

give some examples of systemic autoimmune diseases

A

rheumatoid arthritis

scleroderma

  • systemic lupus erythematosus
  • primary sjögren’s syndrome
  • polymyositis
44
Q

what are cytokines

A

Cytokines are small peptides that are usually
produced and secreted by the cells of the immune
system

Monokines: produced by mononuclear phagocytes:
monocytes
Lymphokines: produced by lymphocytes
Lymphokines and monokines – collectively
CYTOKINES

Cytokines act as a messenger between cells
many cytokines are known as interleukins:
cytokines made by one leukocyte and acting on other leukocytes.

45
Q

what is the function of interleukin-2

A

Interleukin-2 (IL-2) is produced following T cell activation by antigen presenting cells. This cytokine acts in an autocrine loop to induce T cell proliferation

The major autocrine growth factor for T cells.
IL-2 (and IL-15) stimulates NK cell cytolytic function.
Acts on B cells as a growth factor.
Induces the death of activated T cells
IL-2 receptor has 3 chains IL-2Rαβγ. The α chain is the
cytokine specific chain and the γ chain is shared by a
number of cytokine receptors

46
Q

what is the function of Interleukin-4

A

Interleukin-4 (IL-4) is a Th2 derived cytokine that stimulates B cell proliferation

47
Q

what is the function of interleukin-17

A

Interleukin-17 (IL-17) is produced by activated T Helper 17 (Th17) cells

Is a major pro-inflammatory cytokine

48
Q

what is the function of Tumour Necrosis Factor-α (TNF-α)

A

Principle mediator of the anti-bacterial response

49
Q

what is the function of Transforming Growth Factor ( TGF)-β

A

TGF-β generally suppresses lymphocyte function

50
Q

what is the function of interleukin-10

A

IL-10 generally suppresses the immune system

51
Q

what is the major function of chemokine

A

act as a chemoattractant to guide the migration of cells

52
Q

what is chemotaxis

A

Migration of cells along a chemical gradient